Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$2.03 +0.01 (+0.74%)
As of: Oct 21, 2026 · 11:01 AM EDT

Acumen Pharmaceuticals (ABOS) Total Current Liabilities (2021 - 2026)

Updated

Acumen Pharmaceuticals (ABOS) reported Total Current Liabilities of $46.85 million for Q2 2026, up 88.4% from $24.86 million a year earlier and up 60.3% from the prior quarter.

Analysis

Acumen Pharmaceuticals (ABOS) Total Current Liabilities (2021 - 2026) Analysis & Trends

At the end of FY2025, Acumen Pharmaceuticals posted Total Current Liabilities of $30.01 million, up 8.7% from FY2024.

  • Total Current Liabilities has increased for four consecutive years, with a four-year compound annual growth rate of 55.4% (FY2021 to FY2025).
  • By year, Total Current Liabilities came in at $27.61 million in FY2024 (+112.8%), $12.97 million in FY2023 (+66.0%), $7.81 million in FY2022 (+51.8%) and $5.15 million in FY2021.
  • The Q2 2026 figure ranks as the highest quarterly Total Current Liabilities in data going back to Q4 2021.
  • Year over year, Total Current Liabilities has now increased in each of the last nine quarters, with growth averaging 86.0% over the last eight quarters.
  • The high point for year-over-year Total Current Liabilities in five years was Q3 2024 (growth of 226.6%); the low point was Q3 2023 (a decline of 7.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $29.23 million (Q1 2026), $30.01 million (Q4 2025) and $21.96 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,131.80 Bn 1,100.39 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 614.01 Bn 532.53 Bn 17.26 Bn 54.90 Bn
3 AbbVie 503.59 Bn 476.70 Bn 12.70 Bn 41.64 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 297.81 Bn 261.80 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.50 Bn 235.19 Bn 12.86 Bn 31.55 Bn
7 Amgen 236.24 Bn 191.64 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.15 Bn 165.35 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.16 Bn 116.81 Bn 10.94 Bn 32.65 Bn
10 Acumen Pharmaceuticals 146.67 Mn -335.40 Mn - 46.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.85 Mn
Mar 31, 2026 29.23 Mn
Dec 31, 2025 30.01 Mn
Sep 30, 2025 21.96 Mn
Jun 30, 2025 24.86 Mn
Mar 31, 2025 19.32 Mn
Dec 31, 2024 27.61 Mn
Sep 30, 2024 19.91 Mn
Jun 30, 2024 15.37 Mn
Mar 31, 2024 8.47 Mn
Dec 31, 2023 12.97 Mn
Sep 30, 2023 6.10 Mn
Jun 30, 2023 8.53 Mn
Mar 31, 2023 8.78 Mn
Dec 31, 2022 7.81 Mn
Sep 30, 2022 6.61 Mn
Jun 30, 2022 5.13 Mn
Mar 31, 2022 3.94 Mn
Dec 31, 2021 5.15 Mn
API Access

Acumen Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ABOS&period=max&api_key=YOUR_API_KEY